NIH-funded study suggests immune cells rush through channels to get to injured tissue quickly
The jury is still out on whether people at moderate risk of a first heart attack or stroke should take daily aspirin to lower their risk
CURRENT ISSUE - November/December 2025
Preparing Your Lab for the Next Stage